BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7758413)

  • 21. Pathogenesis of HIV.
    Kaplan MH
    Infect Dis Clin North Am; 1994 Jun; 8(2):279-88. PubMed ID: 7916357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Receptor of cells with infection of AIDS virus].
    Xu TG
    Sheng Li Ke Xue Jin Zhan; 1991 Jan; 22(1):29-33. PubMed ID: 1829542
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of gp120 in dendritic cell dysfunction in HIV infection.
    Chougnet C; Gessani S
    J Leukoc Biol; 2006 Nov; 80(5):994-1000. PubMed ID: 16912071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].
    Sorice F; Vullo V; Cirelli A; Catania S; Mastroianni CM; Contini C; Delia S
    Boll Ist Sieroter Milan; 1989; 68(2):115-21. PubMed ID: 2562362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profile of T cell immune responses in HIV-infected children from Uganda.
    Ssewanyana I; Elrefaei M; Dorsey G; Ruel T; Jones NG; Gasasira A; Kamya M; Nakiwala J; Achan J; Charlebois E; Havlir D; Cao H
    J Infect Dis; 2007 Dec; 196(11):1667-70. PubMed ID: 18008251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The proliferative response of HIV+ T-cells (CD4+ and CD8+) are severely suppressed via CD28 coactivation.
    Eylar EH; Báez I; Lefranc CE; Colón-Martínez SL; Rodríguez V; Yamamura Y; Rodriguez N
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):989-93. PubMed ID: 9449531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The naive repertoire of human T helper cells specific for gp120, the envelope glycoprotein of HIV.
    Manca F; Habeshaw J; Dalgleish A
    J Immunol; 1991 Mar; 146(6):1964-71. PubMed ID: 1706385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Towards a vaccine for HIV infection: role of the gp41 envelope protein].
    Debre P; Costagliola D; Legrand R; Vieillard V
    Bull Acad Natl Med; 2009 Jan; 193(1):127-36; discussion 137-8. PubMed ID: 19718985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic and clinical aspects of human immunodeficiency virus infection.
    Romagnani S
    Allergy; 1994 Oct; 49(9):685-95. PubMed ID: 7695056
    [No Abstract]   [Full Text] [Related]  

  • 30. An HIV vaccine--evolving concepts.
    Johnston MI; Fauci AS
    N Engl J Med; 2007 May; 356(20):2073-81. PubMed ID: 17507706
    [No Abstract]   [Full Text] [Related]  

  • 31. HIV and the immune system.
    Rowe PM
    Lancet; 1994 Oct; 344(8929):1081. PubMed ID: 7934459
    [No Abstract]   [Full Text] [Related]  

  • 32. HIV as an inflammatory disease.
    Smith D
    J HIV Ther; 2009 Nov; 14(3):50-1. PubMed ID: 20218238
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunobiology of HIV infection].
    Hattori T
    Uirusu; 2002 Dec; 52(2):245-9. PubMed ID: 12685315
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of CD4 and its downmodulation in establishment and maintenance of HIV-1 infection.
    Bour S; Geleziunas R; Wainberg MA
    Immunol Rev; 1994 Aug; 140():147-71. PubMed ID: 7821926
    [No Abstract]   [Full Text] [Related]  

  • 35. Soluble CD4: another therapeutic option in HIV infection.
    Lancet; 1990 May; 335(8698):1128-30. PubMed ID: 1971867
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immune control of HIV-infection and replication].
    Matsushita S
    Uirusu; 2002 Jun; 52(1):77-82. PubMed ID: 12227184
    [No Abstract]   [Full Text] [Related]  

  • 37. Interactions of HIV-1 with antigen-presenting cells.
    Hewson T; Lone N; Moore M; Howie S
    Immunol Cell Biol; 1999 Aug; 77(4):289-303. PubMed ID: 10457195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TH1/TH2 switching and loss of CD4+ T cells in chronic infections: an immunoendocrinological hypothesis not exclusive to HIV.
    Rook GA; Onyebujoh P; Stanford JL
    Immunol Today; 1993 Nov; 14(11):568-9. PubMed ID: 7903855
    [No Abstract]   [Full Text] [Related]  

  • 39. Secrets of the HIV controllers: A rare group of HIV-positive individuals need no medicine to keep the virus in check. Their good fortune could point the way to more powerful treatments--and perhaps a vaccine.
    Walker BD
    Sci Am; 2012 Jul; 307(1):44-51. PubMed ID: 22779271
    [No Abstract]   [Full Text] [Related]  

  • 40. The low spike density of HIV may have evolved because of the effects of T helper cell depletion on affinity maturation.
    Amitai A; Chakraborty AK; Kardar M
    PLoS Comput Biol; 2018 Aug; 14(8):e1006408. PubMed ID: 30161121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.